Chapter 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/ TOP PLAYER POSITIONING, 2017
3.4. PORTERS FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter 4 CYTOGENETICS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. Consumable

4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by product type

4.2.2.1. Testing kits, media, and reagents

4.2.2.1.1. Market size and forecast

4.2.2.2. Probes

4.2.2.2.1. Market size and forecast

4.2.2.3. Others(affinity reagents and stains)

4.2.2.3.1. Market size and forecast

4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country

4.3. Instrument

4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

4.4. Software & service

4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country

Chapter 5 CYTOGENETICS MARKET, BY TECHNIQUE

5.1. Overview

5.1.1. Market size and forecast

5.2. Comparitive genome hybridization

5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country

5.3. Fluorescence in situ hybridization

5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country

5.4. Karyotyping

5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country

5.5. Immunohistochemistry

5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country

5.6. Others

5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country

Chapter 6 CYTOGENETICS MARKET, BY APPLICATION

6.1. Overview

6.1.1. Market size and forecast

6.2. Genetic disorder

6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country

6.3. Cancer

6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country

6.4. Personalized medicine

6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country

6.5. Other

6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by country

Chapter 7 CYTOGENETICS MARKET, BY END USER

7.1. Overview

7.1.1. Market size and forecast

7.2. Clinical and research laboratory

7.2.1. Market size and forecast, by region
7.2.2. Market analysis, by country

7.3. Pharmaceutical and biotechnology company

7.3.1. Market size and forecast, by region
7.3.2. Market analysis, by country

7.4. Academic Research Institute

7.4.1. Market size and forecast, by region
7.4.2. Market analysis, by country

7.5. Other

7.5.1. Market size and forecast, by region
7.5.2. Market analysis, by country

Chapter 8 CYTOGENETICS MARKET, BY REGION

8.1. OVERVIEW
8.2. NORTH AMERICA

8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast

8.2.2.1. U.S. market size and forecast

8.2.2.1.1. U.S. market size and forecast, by product
8.2.2.1.2. U.S. market size and forecast, by technique
8.2.2.1.3. U.S. market size and forecast, by application
8.2.2.1.4. U.S. market size and forecast, by end user

8.2.2.2. Canada market size and forecast

8.2.2.2.1. Canada market size and forecast, by product
8.2.2.2.2. Canada market size and forecast, by technique
8.2.2.2.3. Canada market size and forecast, by application
8.2.2.2.4. Canada market size and forecast, by end user

8.2.2.3. Mexico market size and forecast

8.2.2.3.1. Mexico market size and forecast, by product
8.2.2.3.2. Mexico market size and forecast, by technique
8.2.2.3.3. Mexico market size and forecast, by application
8.2.2.3.4. Mexico market size and forecast, by end user

8.2.3. North America cytogenetics market, by product
8.2.4. North America cytogenetics market, by technique
8.2.5. North America cytogenetics market, by application
8.2.6. North America cytogenetics market, by end user

8.3. EUROPE

8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast

8.3.2.1. Germany market size and forecast

8.3.2.1.1. Germany market size and forecast, by product
8.3.2.1.2. Germany market size and forecast, by technique
8.3.2.1.3. Germany market size and forecast, by application
8.3.2.1.4. Germany market size and forecast, by end user

8.3.2.2. France market size and forecast

8.3.2.2.1. France market size and forecast, by product
8.3.2.2.2. France market size and forecast, by technique
8.3.2.2.3. France market size and forecast, by application
8.3.2.2.4. France market size and forecast, by end user

8.3.2.3. UK market size and forecast

8.3.2.3.1. UK market size and forecast, by product
8.3.2.3.2. UK market size and forecast, by technique
8.3.2.3.3. UK market size and forecast, by application
8.3.2.3.4. UK market size and forecast, by end user

8.3.2.4. Italy market size and forecast

8.3.2.4.1. Italy market size and forecast, by product
8.3.2.4.2. Italy market size and forecast, by technique
8.3.2.4.3. Italy market size and forecast, by application
8.3.2.4.4. Italy market size and forecast, by end user

8.3.2.5. Spain market size and forecast

8.3.2.5.1. Spain market size and forecast, by product
8.3.2.5.2. Spain market size and forecast, by technique
8.3.2.5.3. Spain market size and forecast, by application
8.3.2.5.4. Spain market size and forecast, by end user

8.3.2.6. Rest of Europe market size and forecast

8.3.2.6.1. Rest of Europe market size and forecast, by product
8.3.2.6.2. Rest of Europe market size and forecast, by technique
8.3.2.6.3. Rest of Europe market size and forecast, by application
8.3.2.6.4. Rest of Europe market size and forecast, by end user

8.3.3. Europe cytogenetics market, by product
8.3.4. Europe cytogenetics market, by technique
8.3.5. Europe cytogenetics market, by application
8.3.6. Europe cytogenetics market, by end user

8.4. ASIA-PACIFIC

8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast

8.4.2.1. Japan market size and forecast

8.4.2.1.1. Japan market size and forecast, by product
8.4.2.1.2. Japan market size and forecast, by technique
8.4.2.1.3. Japan market size and forecast, by application
8.4.2.1.4. Japan market size and forecast, by end user

8.4.2.2. China market size and forecast

8.4.2.2.1. China market size and forecast, by product
8.4.2.2.2. China market size and forecast, by technique
8.4.2.2.3. China market size and forecast, by application
8.4.2.2.4. China market size and forecast, by end user

8.4.2.3. India market size and forecast

8.4.2.3.1. India market size and forecast, by product
8.4.2.3.2. India market size and forecast, by technique
8.4.2.3.3. India market size and forecast, by application
8.4.2.3.4. India market size and forecast, by end user

8.4.2.4. Australia market size and forecast

8.4.2.4.1. Australia market size and forecast, by product
8.4.2.4.2. Australia market size and forecast, by technique
8.4.2.4.3. Australia market size and forecast, by application
8.4.2.4.4. Australia market size and forecast, by end user

8.4.2.5. South Korea market size and forecast

8.4.2.5.1. South Korea market size and forecast, by product
8.4.2.5.2. South Korea market size and forecast, by technique
8.4.2.5.3. South Korea market size and forecast, by application
8.4.2.5.4. South Korea market size and forecast, by end user

8.4.2.6. Rest of Asia-Pacific market size and forecast

8.4.2.6.1. Rest of Asia-Pacific market size and forecast, by product
8.4.2.6.2. Rest of Asia-Pacific market size and forecast, by technique
8.4.2.6.3. Rest of Asia-Pacific market size and forecast, by application
8.4.2.6.4. Rest of Asia-Pacific market size and forecast, by end user

8.4.3. Asia-Pacific cytogenetics market, by product
8.4.4. Asia-Pacific cytogenetics market, by technique
8.4.5. Asia-Pacific cytogenetics market, by application
8.4.6. Asia-Pacific cytogenetics market, by end user

8.5. LAMEA

8.5.1. Key market trends, growth factors and opportunities
8.5.2. Market size and forecast

8.5.2.1. Brazil market size and forecast

8.5.2.1.1. Brazil market size and forecast, by product
8.5.2.1.2. Brazil market size and forecast, by technique
8.5.2.1.3. Brazil market size and forecast, by application
8.5.2.1.4. Brazil market size and forecast, by end user

8.5.2.2. Saudi Arabia market size and forecast

8.5.2.2.1. Saudi Arabia market size and forecast, by product
8.5.2.2.2. Saudi Arabia market size and forecast, by technique
8.5.2.2.3. Saudi Arabia market size and forecast, by application
8.5.2.2.4. Saudi Arabia market size and forecast, by end user

8.5.2.3. South Africa market size and forecast

8.5.2.3.1. South Africa market size and forecast, by product
8.5.2.3.2. South Africa market size and forecast, by technique
8.5.2.3.3. South Africa market size and forecast, by application
8.5.2.3.4. South Africa market size and forecast, by end user

8.5.2.4. Rest of LAMEA market size and forecast

8.5.2.4.1. Rest of LAMEA market size and forecast, by product
8.5.2.4.2. Rest of LAMEA market size and forecast, by technique
8.5.2.4.3. Rest of LAMEA market size and forecast, by application
8.5.2.4.4. Rest of LAMEA market size and forecast, by end user

8.5.3. LAMEA cytogenetics market, by product
8.5.4. LAMEA cytogenetics market, by technique
8.5.5. LAMEA cytogenetics market, by application
8.5.6. LAMEA cytogenetics market, by end user

Chapter 9 COMPANY PROFILES

9.1. Abbott Laboratories

9.1.1. Operating business segments
9.1.2. Business performance
9.1.3. Key strategic moves and developments

9.2. Agilent Technologies, Inc.

9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments

9.3. Applied Spectrial Imaging, Inc.

9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments

9.4. Empire Genomics, LLC

9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments

9.5. Illumina, Inc.

9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments

9.6. Irvine Scientific

9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments

9.7. OPKO Health, Inc.

9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments

9.8. PerkinElmer, Inc.

9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments

9.9. Sysmex Corporation

9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments

9.10. Thermo Fisher Scientific, Inc.

9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and developments